Hospice News June 22, 2021
Holly Vossel

Following the close of the Kindred at Home acquisition in the third quarter, Humana Inc. (NYSE: HUM) plans to spin off and sell the company’s hospice business to capitalize on high market valuations. The company also expects to see substantial cost savings through reduced hospitalizations and skilled nursing admissions as more care moves into the home.

Insurance mammoth Humana in April announced plans to acquire the remaining 60% stake in Kindred at Home for $8.1 billion. This includes Humana’s existing equity value of $2.4 billion from its existing 40% ownership of the business. Humana acquired the 40% stake in 2018, with private equity firms Welsh, Carson, Anderson & Stowe and TPG Capital holding the remaining 60%.

“We expect that we...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Insurance, Mergers & Acquisitions / JV, Payer, Post-Acute Care, Provider, Trends
What the Medicaid unwinding means for plans, providers, and more
What Impact is AI Having on the Collection and Analysis of RWE?
WebMD Ignite launches new member engagement platform for payers
25 payers among Forbes' best employers for diversity
Humana Reports $741 Million Profit And Boosts Medicare Forecast

Share This Article